# Cross-Model Validation Consensus — Session 2026-03-21-scout-006

**Target**: Ferroptosis lipid peroxidation (4-HNE, PUFA-PE oxidation, GPX4 regulation) x Bacterial quorum sensing (AHL autoinducers, LasI/R and RhlI/R systems)

**Date**: 2026-03-21

---

## Methodology

- **GPT-5.4 Pro** (reasoning effort: high, ~26 min): Empirical validation — novelty verification against literature, counter-evidence search, mechanism plausibility assessment, experimental design review. Memory-grounded (knowledge through 2024); preprint/patent coverage marked as insufficient where live search unavailable.
- **Gemini 3.1 Pro** (thinking: HIGH, ~43 sec): Structural and mathematical analysis — formal mappings between dynamical systems, kinetic models, control theory frameworks. Focus on whether connections are formal isomorphisms vs. structural analogies vs. metaphorical similarity.

Both models received all 6 hypotheses. This report synthesizes their assessments, with primary focus on the top 3 (H2.1, H2.3, H2.2).

---

## Per-Hypothesis Consensus

---

### H2.1 — Pyocyanin-GPX4-Ferroptosis Bidirectional Axis

| Dimension | GPT-5.4 Pro | Gemini 3.1 Pro | Consensus |
|---|---|---|---|
| Novelty | PARTIALLY EXPLORED | Structural correspondence (confidence 9/10) | Agree: organism-level link known (Dar 2018); bidirectional iron feedback loop novel |
| Confidence | 6/10 (down from 7) | 9/10 structural | Diverge: GPT reduces on empirical gaps; Gemini assigns high structural confidence |
| Mechanism | MODERATE — coherent but broad oxidant; specificity unproven | Non-linear bifurcation at GPX4 threshold (saddle-node dynamical system) | Converge on threshold/tipping-point nature; diverge on empirical grounding |
| Testability | MEDIUM feasibility; two-stage experiment required | Titrate PYO into GPX4+/- cells, map step-function in lipid ROS via BODIPY-C11 | Compatible approaches |

**GPT confidence update**: Downgrade from 7 to 6/10. PYO→oxidative stress/GSH depletion is solid; but the GPX4-specific ferroptosis branch and the ferroptosis→siderophore iron feedback remain indirect. Non-ferroptotic death modes (apoptosis, necrosis) are a major confounder. Iron buffering by lactoferrin/transferrin weakens the iron-acquisition prediction. Pyoverdine reporter may decrease rather than increase when iron is released in excess.

**Gemini structural assessment**: Models the system as a coupled non-linear ODE pair where QS-controlled pyocyanin acts as an exogenous forcing function depleting the damping coefficient (GPX4/GSH) in the host peroxidation cascade. The bifurcation threshold is identifiable computationally: when k₂·[GSH]² < α (propagation rate), the host crosses into runaway ferroptosis. Structural confidence 9/10 for the mathematical architecture; this is a structural correspondence, not metaphorical.

**Agreement areas**: Both models recognize the threshold (tipping-point) character of GPX4 inactivation. Both flag the synergy between PYO-depleting GSH and the downstream peroxidation cascade as coherent. Both agree Dar et al. 2018 partially anchors the territory.

**Divergence areas**: GPT is skeptical of the quantitative claims (iron release amounts, siderophore capture specifics). Gemini does not address empirical feasibility. GPT downgrades on lack of pyocyanin-specific ferroptosis evidence; Gemini's high confidence reflects structural coherence not biological validation.

**Combined recommendation**: PROMISING — pursue H2.1 after first establishing that pyocyanin induces ferrostatin-rescuable ferroptosis specifically (Stage 1 before iron-acquisition arm). Use BODIPY-C11 + 15-HOO-AA-PE lipidomics as definitive ferroptosis markers.

---

### H2.2 — GPX4 as Inter-Kingdom Signal Gatekeeper with Extracellular Scavenging Budget

| Dimension | GPT-5.4 Pro | Gemini 3.1 Pro | Consensus |
|---|---|---|---|
| Novelty | NOVEL as inter-kingdom quantitative framework | Formal isomorphism with Zener diode / capacitive breakdown (confidence 8/10) | Strong agreement: novel framework, both models validate the conceptual originality |
| Confidence | 4.5/10 (down from 6) | 8/10 structural | Diverge sharply on confidence: GPT penalizes quantitative errors; Gemini rates the mathematical structure highly |
| Mechanism | MODERATE-LOW — scavenging budget numbers tissue-dependent; airway GSH much higher than assumed | Heaviside step-function: bacterial signal is zero until exact moment extracellular thiol "capacitance" exhausted | Converge on threshold/discontinuity character; diverge on whether tissue values support it |
| Testability | MEDIUM — measure free 4-HNE + thiol budget directly before modeling | Transwell system: bacteria should activate discontinuously (step-function) not linearly with 4-HNE production rate | Complementary; Gemini's discontinuity prediction is a strong experimental handle |

**GPT confidence update**: Downgrade from 6 to 4.5/10. The conceptual framework is novel, but the stated scavenging budget numbers are wrong for the most relevant tissue (airway surface liquid GSH is 100–400 µM, not 2–5 µM as the hypothesis assumes). Albumin in airway lining fluid is also lower than plasma. These errors do not disprove the model — they require it to be re-parameterized with direct measurements. GSH supplementation experiments are confounded because GSH also affects host redox and bacterial metabolism directly.

**Gemini structural assessment**: Maps to a formal isomorphism with electronic Zener diode breakdown or acid-base titration. The bacterial signal is mathematically zero until the scavenging capacitance (summed extracellular thiols) is fully discharged. Predicts a Heaviside step-function activation of QS — not gradual tracking. This is characterized as a Formal isomorphism (confidence 8/10) and provides the strongest experimental discriminator in the entire set: the bacteria should activate in a discrete jump, not in a graded manner.

**Agreement areas**: Both models independently arrive at a threshold/discontinuity structure (GPT calls it "budget collapse," Gemini calls it "capacitor breakdown"). This convergence on the same mathematical structure from two different angles is the strongest validation this hypothesis receives.

**Divergence areas**: GPT substantially downgrades due to incorrect quantitative premises. Gemini gives high structural confidence precisely because the mathematical structure is clean, without evaluating whether the biology supports the assumed parameter values. The gap is fundamental: the framework is structurally elegant but empirically underspecified.

**Combined recommendation**: PROMISING WITH REQUIRED PARAMETER WORK — the Heaviside step-function prediction from Gemini is a strong falsifiable experimental target. But the hypothesis needs re-parameterization: measure actual free 4-HNE and thiol budgets in airway surface liquid or burn wound exudate before any co-culture work. Use carnosine/hydralazine as aldehyde scavengers (less confounding than GSH). This may be more relevant to burn wounds or ischemic tissue than healthy airway.

---

### H2.3 — Dual-Pathway PYO + LoxA Synergy

| Dimension | GPT-5.4 Pro | Gemini 3.1 Pro | Consensus |
|---|---|---|---|
| Novelty | PARTIALLY EXPLORED — each pathway known; synergy model novel | Structural analogy with damped driven oscillator / resonance catastrophe (confidence 8/10) | Agree: component literature exists; the sequential synergy and super-additivity prediction are novel |
| Confidence | 7.5/10 (up from 7) | 8/10 structural | High agreement across both models — strongest consensus in the set |
| Mechanism | HIGH-MODERATE — cleanest mechanistic logic: LoxA generates PLOOH lesion, PYO removes GPX4 defense | LoxA = external driving force F(t); PYO = reduction of damping coefficient c→0. Synergy is multiplicative (X×Y), not additive | Converge on multiplicative synergy architecture; Gemini provides quantitative prediction for FIC index |
| Testability | HIGH feasibility — isogenic 2×2 mutant matrix is standard | Isobologram / FIC index; predicts FIC < 0.2 (profound non-linear synergy) | Highly complementary — GPT proposes the genetic experiment, Gemini provides the quantitative prediction to test |

**GPT confidence update**: Upgrade from 7 to 7.5/10. This hypothesis integrates one known ferroptosis effector (LoxA, Dar et al. 2018) with one well-established oxidative virulence factor (pyocyanin) in a clean, testable synergy architecture. The logic "one factor generates the lethal lesion, the other removes the defense" is biologically sound even if timing details are uncertain. Best feasibility rating in the set.

**Gemini structural assessment**: Maps to second-order linear ODEs with variable damping — the control theory model of resonance catastrophe. LoxA provides the driving force F(t) = k_LoxA[AA-PE] while PYO systematically reduces the host's antioxidant damping coefficient c→0. This predicts multiplicative (not additive) synergy: damage(WT) ≈ damage(LoxA) × damage(PYO). FIC index < 0.2 is the quantitative prediction. This is a structural analogy (same mathematical structure, different physical quantities), confidence 8/10.

**Agreement areas**: This is the highest-agreement hypothesis in the entire set. Both models independently assign confidence ~7.5–8/10. Both characterize the synergy as super-additive (GPT: "beyond additive," Gemini: "multiplicative X×Y"). Both cite Dar et al. 2018 as establishing the LoxA arm. Both see the 2×2 mutant matrix as the right experimental design.

**Divergence areas**: GPT flags LoxA expression variability across strains and environments as a practical concern. Gemini does not address strain variability. Minor divergence on how to express the quantitative prediction (Bliss excess vs. FIC index — these are compatible and Gemini's FIC < 0.2 is actionable).

**Combined recommendation**: HIGH PRIORITY — strongest experimental candidate in the set. Both frontier models agree without prompting. The experiment is executable with standard microbiology tools. The quantitative prediction (multiplicative synergy, FIC < 0.2) is specific. Run this first.

---

### H1' — 4-HNE Covalent Modification of Holo-LasR

| Dimension | GPT-5.4 Pro | Gemini 3.1 Pro | Consensus |
|---|---|---|---|
| Novelty | NOVEL — 4-HNE→LasR covalent mechanism not reported | Formal isomorphism with continuous-time node deletion in directed regulatory graph (confidence 7/10) | Agree on novelty; differ in framing — GPT skeptical of biological relevance, Gemini rates mathematical structure favorably |
| Confidence | 3/10 (down from 5) | 7/10 structural | Diverge: GPT focuses on cell-entry barriers and promiscuity problems; Gemini focuses on mathematical elegance |
| Mechanism | LOW-MODERATE — purified adduct is possible; specific QS modulation in live bacteria is much less plausible | [LasR_unmodified](t) = [LasR₀] × e^(−k[4-HNE]t) → exponential node deletion in QS network | Diverge on plausibility: GPT skeptical of specificity; Gemini frames as clean mathematical model |
| Testability | MEDIUM — purified holo-LasR adduct MS/EMSA is feasible first-pass; cell-based is harder | Temporal recovery integral after 4-HNE pulse; lag time should match LasR resynthesis time | Compatible designs; cell-based is required to validate the network prediction |

**GPT confidence update**: Downgrade from 5 to 3/10. Critical barriers: (1) 4-HNE must cross the Gram-negative envelope; (2) bacterial GSH and aldehyde detox enzymes (alkenal reductases, ALDH, glutathione transferases) compete; (3) OxyR/SoxR-like redox sensors are more abundant and accessible electrophile targets than LasR; (4) many clinical PA isolates are LasR-defective. The purified biochemistry is feasible but the jump to specific QS modulation in living bacteria is not supported.

**Gemini structural assessment**: Models 4-HNE as performing exponential decay of the LasR node in the QS regulatory network, mapping to continuous-time node deletion in a directed graph. Predicts that a short 4-HNE pulse induces "QS blindness" lasting precisely as long as the bacterial LasR resynthesis time (not competitive inhibition recovery, but genuine de novo resynthesis lag). This is a formal isomorphism, confidence 7/10. The resynthesis-lag prediction is a distinctive and testable experimental signature.

**Agreement areas**: Both models agree this is novel. Gemini's resynthesis-lag prediction provides a unique experimental discriminator that GPT's design could incorporate (measure LasR protein recovery kinetics post-pulse, not just reporter recovery). Both agree biochemical adduct MS should come first.

**Divergence areas**: GPT is skeptical that biologically specific LasR modulation occurs in living bacteria (due to promiscuity and cell-entry barriers). Gemini treats it as a strong formal model. This divergence is meaningful — it reflects that mathematical structure and biological feasibility are genuinely different questions here.

**Combined recommendation**: SPECULATIVE — DO BIOCHEMISTRY FIRST. The purified holo-LasR adduct MS/EMSA experiment is the decision gate. If no adduct forms or if adducts are nonspecific relative to control proteins, retire the hypothesis. If adducts form with specificity, add Gemini's resynthesis-lag test as the in vivo discriminator. Low overall priority given GPT's feasibility concerns.

---

### H2.5 — Bacterial Lactonase Degrades 4-HNE Lactol

| Dimension | GPT-5.4 Pro | Gemini 3.1 Pro | Consensus |
|---|---|---|---|
| Novelty | NOVEL — no prior art found | Metaphorical similarity only — flagged as low scientific productivity | Agree: novel but for the wrong reason (no prior art ≠ viable mechanism) |
| Confidence | 1.5/10 (down from 4) | 9/10 confidence that hypothesis is FLAWED | Converge strongly — both models independently reach near-rejection |
| Mechanism | LOW — hemiacetal ≠ lactone ester; substrate chemistry mismatch | Metaphorical (flagged) — ring size shared but quantum mechanical operators (bond enthalpies, electron localization) do not map; AiiA cannot catalyze | Full convergence on mechanism failure |
| Testability | HIGH (easy falsification experiment) | QM/MM computational dock confirms lack of transition state | Compatible null-test designs; computational and biochemical approaches both predict failure |

**GPT assessment**: Hard chemistry problem. AiiA's catalytic logic requires nucleophilic attack on a lactone carbonyl ester. The lactol ring of 4-HNE lacks this carbonyl. Even if some hydrolysis-like event occurred, the product would regenerate 4-HNE (the hemiacetal simply ring-opens to the aldehyde), providing no detoxification. AiiA also originates from Bacillus, not P. aeruginosa. Updated confidence: 1.5/10.

**Gemini structural assessment**: Explicitly flags this as metaphorical similarity — the lowest category (not scientifically productive). Subgraph isomorphism on ring connectivity exists but the quantum mechanical operators (bond enthalpies, electron localization functions) do not map. The catalytic triad of AiiA requires nucleophilic attack on a rigid carbonyl carbon with partial positive charge (δ+), which the lactol's hemiacetal carbon lacks. Confidence 9/10 that the hypothesis is chemically flawed.

**Agreement areas**: Near-total convergence. Two models using entirely different analytical frameworks (empirical chemistry review vs. formal QM structure analysis) both independently conclude the mechanism is chemically invalid.

**Combined recommendation**: RUN A QUICK NULL TEST AND RETIRE. One week, one experiment (purified AiiA + isotopically labeled 4-HNE + LC-MS). If no new products detected, permanently deprioritize. The high experimental feasibility means this can be falsified cheaply and quickly.

---

### H2.6 — ACSL4 as Tissue-Specific Vulnerability Map

| Dimension | GPT-5.4 Pro | Gemini 3.1 Pro | Consensus |
|---|---|---|---|
| Novelty | PARTIALLY EXPLORED — ACSL4 known; tissue-map-for-QS-crosstalk aspect novel | Structural correspondence — spatial convolution of ACSL4 vulnerability field with PYO diffusion field | Agree: ACSL4's role in ferroptosis known; spatial mapping to QS cross-talk intensity is a novel framing |
| Confidence | 4/10 (down from 5) | 7/10 structural | Moderate divergence: GPT penalizes multi-factor complexity; Gemini provides strong spatial prediction |
| Mechanism | MODERATE — ACSL4 is a real modifier but not a stand-alone map; 4-HNE production does not map cleanly onto ACSL4 | Damage(x,y) = V(x,y) * P(x,y): spatial convolution of ACSL4 vulnerability matrix with PYO diffusion radial field | Diverge in framing: GPT sees oversimplification, Gemini provides tractable spatial model |
| Testability | MEDIUM — replace A549/HepG2 with isogenic ACSL4 KO/rescue | Spatial transcriptomics or MALDI-MS imaging to map PUFA-OOH zone boundaries predicted by convolution integral | Complementary: GPT provides genetic control, Gemini provides spatial readout |

**GPT assessment**: ACSL4 is a real determinant of ferroptosis susceptibility (Doll et al. 2017) but is one factor among many (GPX4, FSP1, DHODH, GCH1/BH4, ALDH/GSTA4). 4-HNE generation also depends heavily on linoleate pools, not only ACSL4-enriched AA/AdA pools. A549 cells have KEAP1 mutations activating NRF2, confounding ferroptosis sensitivity comparisons. Liver is not a low-ferroptosis tissue in disease contexts. Updated confidence: 4/10.

**Gemini structural assessment**: Models ACSL4 as defining a spatial vulnerability field V(x,y) and the bacterial biofilm as a radial PYO diffusion source P(x,y). The predicted ferroptotic damage is the spatial convolution Damage(x,y) = V(x,y) * P(x,y). This predicts "halos" of cell death around biofilm foci whose radii are computable from the ratio of PUFA-PE integration rate to pyocyanin diffusion coefficient. Structural correspondence, confidence 7/10. The spatial prediction is uniquely testable via MALDI-MS imaging.

**Agreement areas**: Both models agree ACSL4 is a real but not sufficient predictor. The spatial convolution framing from Gemini actually rescues the hypothesis from being merely a "tissue map" — it turns it into a quantitative spatial model with testable geometric predictions.

**Combined recommendation**: PROMISING AS SPATIAL MODEL — reframe from a tissue-type comparison to a spatial gradient experiment. Gemini's convolution model predicts measurable "zones of clearance" whose geometry is computable. Use MALDI-MS imaging of PUFA-OOH distribution around a P. aeruginosa colony on ACSL4-manipulated cell monolayers. Replace A549/HepG2 with isogenic ACSL4 KO/rescue in one background.

---

## Summary

### High-Priority Candidates (both models assign high confidence, strong agreement)

- **H2.3 — PYO + LoxA Synergy**: Highest agreement in the set (GPT 7.5/10, Gemini 8/10 structural). Both independently characterize synergy as multiplicative. Experiment is clearly defined: isogenic 2×2 mutant matrix + Bliss excess / FIC index < 0.2. Run this first.

### Promising (strong structure, requires empirical grounding or re-parameterization)

- **H2.1 — Pyocyanin-GPX4 Bidirectional Axis**: Both models converge on threshold/bifurcation architecture. GPT downgrades on specificity gaps. Execute Stage 1 (pyocyanin → ferrostatin-rescuable ferroptosis) before Stage 2 (iron-acquisition feedback).
- **H2.2 — GPX4 Gatekeeper / Scavenging Budget**: Gemini's Heaviside step-function prediction provides the strongest experimental discriminator (bacteria should activate discontinuously, not gradually). But quantitative premises need remeasurement in tissue-relevant compartment. May be most valid in burn wounds, not healthy airway.
- **H2.6 — ACSL4 Vulnerability Map**: Reframed as a spatial convolution model (Gemini), this becomes testable with MALDI-MS imaging. Use isogenic ACSL4 perturbation, not cross-line comparisons.

### Speculative (novel but major barriers)

- **H1' — 4-HNE Covalent Modification of LasR**: Novel chemistry, interesting resynthesis-lag prediction (Gemini). But GPT identifies cell-entry barriers, competing electrophile targets (OxyR/SoxR), and LasR inaccessibility as serious concerns. Do biochemistry first; abandon quickly if no specific adduct.

### Likely Dead End (both models independently reject)

- **H2.5 — Lactonase Degrades 4-HNE Lactol**: Both models converge on mechanism failure (hemiacetal ≠ lactone ester; product would still be 4-HNE). Novel only by absence of prior art. Run 1-week null test for clean closure.

---

## Confidence Adjustment Summary

| Hypothesis | Internal Score | GPT Updated | Gemini Structural | Combined Verdict |
|---|---|---|---|---|
| H2.1 | 7/10 | 6/10 ↓ | 9/10 | PROMISING — bifurcation architecture confirmed; iron feedback ungrounded |
| H2.2 | 6/10 | 4.5/10 ↓↓ | 8/10 | PROMISING — re-parameterize scavenging budget first; Heaviside prediction valuable |
| H2.3 | 7/10 | 7.5/10 ↑ | 8/10 | HIGH PRIORITY — highest consensus; multiplicative synergy; run immediately |
| H1' | 5/10 | 3/10 ↓↓ | 7/10 | SPECULATIVE — biochemistry gate required |
| H2.5 | 4/10 | 1.5/10 ↓↓↓ | 9/10 (flawed) | DEAD END — null test then retire |
| H2.6 | 5/10 | 4/10 ↓ | 7/10 | PROMISING AS SPATIAL MODEL — reframe with MALDI-MS imaging |

---

## Next Steps

1. **Immediate**: Run the H2.3 isogenic 2×2 mutant matrix experiment. The experiment is well-defined by both models. Target FIC index < 0.2 as the quantitative success criterion for multiplicative synergy.
2. **Parallel quick gate**: Run the H2.5 null test (AiiA + isotopic 4-HNE, LC-MS, 1 week). Clean falsification with minimal resource expenditure.
3. **Before H2.1 co-culture**: First confirm that pyocyanin induces ferrostatin-rescuable ferroptosis specifically in airway cells (C11-BODIPY + 15-HOO-AA-PE lipidomics as markers; RSL3 as positive control).
4. **Before H2.2 co-culture**: Directly measure free 4-HNE and extracellular thiol budget (GSH, albumin-SH) in the actual infection compartment (airway surface liquid or burn exudate). Re-parameterize the threshold model with measured values.
5. **H1' biochemistry gate**: Purified holo-LasR LBD + isotopic 4-HNE → intact MS + EMSA on LasR target promoter. If adducts are absent or nonspecific: retire. If adducts form: test the resynthesis-lag prediction (Gemini's distinctive experimental signature).
6. **H2.6 spatial experiment**: Plate ACSL4 KO/rescue monolayer, spot P. aeruginosa in center, map PUFA-OOH zone boundary via MALDI-MS imaging. Compare measured boundary geometry to predicted convolution integral (compute from ACSL4 density and PYO diffusion coefficient).
7. **Domain experts to consult**: Lipid peroxidation specialist for PLOOH lipidomics setup; P. aeruginosa genetics lab for mutant construction; mass spectrometry facility for intact-protein adduct mapping (H1').

---

*Validation performed: 2026-03-21. GPT-5.4 Pro response: 1548s (reasoning: high). Gemini 3.1 Pro response: 43s (thinking: HIGH). Both API calls completed. No citations fabricated.*
